Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Common Equity (2016 - 2025)

United Health Products' Common Equity history spans 15 years, with the latest figure at -$3.9 million for Q4 2025.

  • Quarterly results put Common Equity at -$3.9 million for Q4 2025, down 58.62% from a year ago — trailing twelve months through Dec 2025 was -$3.9 million (down 58.62% YoY), and the annual figure for FY2025 was -$3.9 million, down 58.62%.
  • Common Equity for Q4 2025 was -$3.9 million at United Health Products, down from -$3.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $41273.0 in Q1 2021 to a low of -$3.9 million in Q4 2025.
  • The 5-year median for Common Equity is -$2.0 million (2023), against an average of -$2.0 million.
  • The sharpest move saw Common Equity skyrocketed 106.32% in 2021, then crashed 4981.31% in 2022.
  • Year by year, Common Equity stood at -$1.1 million in 2021, then plummeted by 80.83% to -$2.1 million in 2022, then grew by 16.98% to -$1.7 million in 2023, then plummeted by 42.56% to -$2.4 million in 2024, then plummeted by 58.62% to -$3.9 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$3.9 million, -$3.3 million, and -$3.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.